January 04, 2023

Actavis Laboratories FL, Inc. v. US

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 21, 2023

    Fed. Circ. Urged To Upend Actavis' $12M Legal Fee Deduction

    The Federal Circuit should reverse a decision allowing drugmaker Actavis to deduct as regular business expenses $12 million it spent fighting lawsuits as it tried to secure approval to sell generic birth control and other drugs, the government argued.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login